A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Claritin Indications, Dosage, Storage, Stability - Loratadine
Claritin Indications, Dosage, Storage, Stability - Loratadine
INDICATIONS
Loratadine is indicated for the relief of nasal and non-nasal symptoms of seasonal allergic rhinitis and for the
treatment of chronic idiopathic urticaria in patients 2 years of age or older
DOSAGE AND ADMINISTRATION
Adults and children 6 years of age and over: The recommended dose of CLARITIN is
one 10 mg tablet or reditab, or 2 teaspoonfuls (10 mg) of syrup once daily.
Children 2 to 5 years of age: The recommended dose of CLARITIN Syrup is 5 mg (1 teaspoonful) once daily.
In adults and children 6 years of age and over with liver failure or renal insufficiency (GFR < 30 mL/min), the starting
dose should be 10 mg (one tablet or two teaspoonfuls) every other day. In children 2 to 5 years of age with liver failure
or renal insufficiency, the starting dose should be 5 mg (one teaspoonful) every other day.
Administration of CLARITIN REDITABS (loratadine rapidly-disintegrating tablets): Place CLARITIN REDITABS
(loratadine rapidly-disintegrating tablets) on the tongue. Tablet disintegration occurs rapidly. Administer with or without
water.
HOW SUPPLIED
CLARITIN Tablets: 10 mg, white to off-white compressed tablets; impressed with the product identification
number “458” on one side and “CLARITIN 10” on the other; high-density polyethylene plastic bottles of 100 (NDC 0085-0458-03)
and 500 (NDC 0085-0458-06). Also available, CLARITIN Unit-of-Use packages of 30 tablets (10 tablets per blister card)
(NDC 0085-0458-05); and 10 x 10 tablet Unit Dose-Hospital Pack (NDC 0085-0458-04).
Protect Unit-of-Use packaging and Unit Dose-Hospital Pack from excessive moisture.
Store between 2° and 30°C (36° and 86°F).
CLARITIN Syrup: Clear, colorless to light-yellow liquid, containing 1 mg loratadine per mL; amber
glass bottles of 16 fluid ounces (NDC 0085-1223-01).
Store between 2° and 25°C (36° and 77°F).
CLARITIN REDITABS (loratadine rapidly-disintegrating tablets): CLARITIN REDITABS (loratadine rapidly-disintegrating
tablets), 10 mg, white to off-white blister-formed tablet; impressed with the letter “C” on one side; Unit-of-Use
polyvinyl chloride blister packages of 30 tablets (three laminated foil pouches, each containing one blister card of
10 tablets) supplied with Patient’s Instructions for Use (NDC 0085-1128-02).
Keep CLARITIN REDITABS (loratadine rapidly-disintegrating tablets) in a dry place.
Store between 2° and 25°C (36° and 77°F). Use within 6 months of opening laminated foil pouch, and immediately
upon opening individual tablet blister.
top
